ACS (excluding AMI): 2 trials - PLATO - DISPERSE-2 (90mg)
All type of patients: 2 trials - PLATO - DISPERSE-2 (90mg)
All type of patients: 2 trials - PEGASUS 60mg - PEGASUS 90mg
Secondary prevention in patients with CAD: 2 trials - PEGASUS 60mg - PEGASUS 90mg
Secondary prevention: 2 trials - PEGASUS 60mg - PEGASUS 90mg
Secondary prevention in patients with intermittent claudication: 1 trials - EUCLID